Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus

American Journal of Health-System Pharmacy

Volumn 68, Issue 1, 2011, Pages 69-72

  Fohl, Alexander L ^a,b   Johnson, Cary E ^c,d   Cober, M Petrea ^e,f  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UM ^*  (United States)

^d UMHHC   (United States)

^e NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^f AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

Acetylcysteine; Chromatography liquid; Color; Compounding; Concentration; Diluents; Hydrogen ion concentration; Hydrogen sulfide; Ileus; Mucolytic agents; Odors; Sodium chloride; Stability; Storage

Indexed keywords

ACETYLCYSTEINE; HYDROGEN SULFIDE; SODIUM CHLORIDE;

ARTICLE; COLOR; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUTION; DRUG STABILITY; DRUG SYNTHESIS; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MECONIUM ILEUS; ODOR; PH; PRESCRIPTION; PRIORITY JOURNAL; ROOM TEMPERATURE; DRUG EFFECT; HUMAN; ILEUS; MECONIUM; NEWBORN; NEWBORN DISEASE; ORAL DRUG ADMINISTRATION; SOLUTION AND SOLUBILITY;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; ILEUS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MECONIUM; SOLUTIONS;

EID: 79953009421     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100214     Document Type: Article

References (22)

1. American Pregnancy Association. www.americanpregnancy.org/main/ statistics.html (accessed 2010 Mar 29).
2. Honeyman MS, Siker E. Cystic fibrosis of the pancreas: an estimate of the incidence. Am J Hum Genet. 1965; 17:461-5.
3. Buchanan DJ, Rapoport S. Chemical comparison of normal meconium and meconium from a patient with meconium ileus. Pediatrics. 1952; 9:304-10.
4. Shaw A. Safety of N-acetylcysteine in treatment of meconium obstruction in the newborn. J Pediatr Surg. 1969; 4:119-25.
5. Anaizi NH, Swenson CF. Instability of aqueous captopril solutions. Am J Hosp Pharm. 1993; 50:486-8. (Pubitemid 23083716)
6. Anaizi NH, Swenson CF, Dentinger PJ. Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution. Am J Health-Syst Pharm. 1997; 54:549-53. (Pubitemid 27114431)
7. Siden R, Johnson CE. Stability of a flavored formulation of acetylcysteine for oral administration. Am J Health-Syst Pharm. 2008; 65:558-61. (Pubitemid 351429718)
8. Burke M, Ragi J, Karamanoukian H et al. New strategies in nonoperative management of meconium ileus. J Pediatr Surg. 2002; 37:760-4. (Pubitemid 34517451)
9. Cooke A, Deshpande A, Wong C et al. Hepatic derangement following N-acetylcysteine enemas in an infant with cystic fibrosis. J Paediatr Child Health. 2008; 44:673-5.
10. Langer J, Paes B, Gray S. Hypernatremia associated with n-acetylcysteine therapy for meconium ileus in a premature infant. Can Med Assoc J. 1990; 143:202-3. (Pubitemid 20254793)
11. Perman J, Breslow L, Ingall D. Nonoperative treatment of meconium ileus equivalent. Am J Dis Child. 1975; 129:1210-1.
12. Simpson T, Lynn H, Burgert E. Nonoperative treatment of meconium ileus: report of a case. Mayo Clin Proc. 1968; 43:725-9.
13. Emil S, Nguyen T, Sills J et al. Meconium obstruction in extremely low-birth-weight neonates: guidelines for diagnosis and management. J Pediatr Surg. 2004; 39:731-7. (Pubitemid 38637924)
14. Steiner Z, Mogilner J, Siplovich L et al. T-tubes in the management of meconium ileus. Pediatr Surg Int. 1997; 12:140-1. (Pubitemid 27148396)
15. Millar A, Rode H, Cywes S. Management of uncomplicated meconium ileus with T tube ileostomy. Arch Dis Child. 1988; 63:309-10. (Pubitemid 18094672)
16. Lillibridge C, Docter J, Eidelman S. Oral administration of n-acetylcysteine in the prophylaxis of "meconium ileus equivalent." J Pediatr. 1967; 71:887-9.
17. Andersen H, Hjelt K, Waever E et al. The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of high-energy intake. J Pediatr Gastroenterol Nutr. 1990; 11:356-60. (Pubitemid 20308962)
18. The United States pharmacopeia, 32nd rev., and The national formulary, 27th ed. Rockville, MD: United States Pharmacopeial Convention; 2010:1423-4.
19. Karabit M, Juneskans O, Lundgren P. Studies on the evaluation of preservative efficacy - II. The determination of antimicrobial characteristics of benzyl alcohol. J Clin Hosp Pharm. 1986; 11:281-9. (Pubitemid 16038945)
20. Reidmiller J, Smith W, Sawyer M et al. Antimicrobial properties of the chelating agent EDTA on streptococcal bovine mastitis isolates. J Food Prot. 2006; 69:1460-2. (Pubitemid 43887095)
21. Farca A, Nebbia P, Robino P et al. Effects of the combination antibiotic EDTA-Tris in the treatment of chronic bovine endometritis caused by antimicrobial-resistant bacteria. Pharmacol Res. 1997; 36:35-9. (Pubitemid 27458578)
22. Kiser T, Oldland A, Fish D. Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings. Am J Health-Syst Pharm. 2007; 64:762-6. (Pubitemid 46515556)